Hy-Tech Engineers is leading the three IPOs in grey market premium terms after Day 3, with an implied 75.47% listing gain, ahead of Symbiotec Pharmalab and Skyways Air Services.
NEW DELHI, India — Hy-Tech Engineers, Symbiotec Pharmalab and Skyways Air Services have completed Day 3 of their four-day IPO subscription period, with investor attention focused on grey market premium (GMP), subscription demand and possible listing gains. Based on the latest GMP figures provided, Hy-Tech Engineers is signalling the highest potential percentage gain among the three issues.
Key Highlights
- Hy-Tech Engineers leads with a GMP of Rs 40 and an implied listing gain of 75.47%.
- Symbiotec Pharmalab has a GMP of Rs 340, indicating a potential 34.41% premium.
- Skyways Air Services has a GMP of Rs 29, implying a possible 21.1% listing gain.
- Hy-Tech Engineers recorded 50.86 times subscription by the end of Day 3.
- All three IPOs are scheduled to close on August 27, with allotment expected on August 28.
Hy-Tech Engineers IPO GMP Leads at 75.47%
Hy-Tech Engineers is currently showing the strongest grey market indication among the three IPOs. Its GMP stands at Rs 40 against the upper issue price of Rs 53, resulting in an estimated listing price of Rs 93.
At that level, the implied listing premium works out to 75.47%. The issue also attracted the strongest investor demand among the three, with subscription reaching 50.86 times by the end of Wednesday.
The Rs 135.73 crore issue consists of a Rs 60 crore fresh issue and a Rs 75.73 crore offer for sale. The minimum retail lot is 283 shares, requiring Rs 14,999 at the upper price band.
Symbiotec Pharmalab IPO GMP and Subscription
Symbiotec Pharmalab ranks second on the basis of percentage listing premium indicated by the current GMP. The pharmaceutical company has a GMP of Rs 340 against an upper price band of Rs 988.
This combination points to an estimated listing price of Rs 1,328 and an implied premium of 34.41%. The issue had been subscribed 5.31 times by the end of Wednesday.
The Rs 1,757 crore IPO includes a Rs 150 crore fresh issue and a Rs 1,607 crore offer for sale. Retail investors can bid for a minimum of 15 shares, requiring Rs 14,820 at the upper price band.
Skyways Air Services IPO GMP Signals 21.1% Gain
Skyways Air Services is currently showing a GMP of Rs 29. With the upper price band fixed at Rs 138, the unofficial market indication points to an estimated listing price of Rs 167.
This represents a potential listing gain of 21.1% based on the supplied GMP figures. The minimum retail lot consists of 100 shares, translating into an investment of Rs 13,800 at the upper price band.
IPO GMP Comparison: Hy-Tech Engineers vs Symbiotec vs Skyways
| IPO | GMP | Upper Price Band | Estimated Listing Price | Implied Gain |
|---|---|---|---|---|
| Hy-Tech Engineers | Rs 40 | Rs 53 | Rs 93 | 75.47% |
| Symbiotec Pharmalab | Rs 340 | Rs 988 | Rs 1,328 | 34.41% |
| Skyways Air Services | Rs 29 | Rs 138 | Rs 167 | 21.1% |
The comparison shows Hy-Tech Engineers clearly ahead in percentage terms based on the current GMP. Symbiotec Pharmalab follows, while Skyways Air Services has the lowest implied percentage premium among the three.
Which IPO Could Deliver the Highest Listing Gain?
On the basis of the supplied grey market figures, Hy-Tech Engineers currently signals the highest potential listing gain at 75.47%. Its Rs 40 GMP over a Rs 53 upper issue price also translates into the largest estimated absolute gain per retail lot among the three.
For a 283-share Hy-Tech Engineers lot, a Rs 40 GMP implies an indicative gain of Rs 11,320. Symbiotec Pharmalab’s Rs 340 GMP on a 15-share lot indicates Rs 5,100, while Skyways Air Services’ Rs 29 GMP on 100 shares indicates Rs 2,900.
What Are the IPO Allotment and Listing Dates?
All three issues are scheduled to close their subscription on August 27. The additional subscription day is linked in the supplied information to August 26 being a settlement holiday.
Allotment for the three IPOs is expected on August 28, while shares are scheduled to list on the BSE and NSE on September 1.
GMP Is Not a Guaranteed Listing Indicator
Grey market premium figures are unofficial and speculative. They can change before listing depending on market sentiment, demand and other market conditions, so the indicated listing price should not be treated as a confirmed outcome.
Investors should review the relevant offer documents and consider the risks before participating in any IPO.
Financial disclaimer: This article is for informational purposes only and should not be treated as investment advice. IPO investments are subject to market risks.
Praveen Yadav is the Founder and Editor at The Nation Bulletin. With over 3 years of experience in digital journalism and news reporting, he covers national affairs, governance, and breaking current events with a commitment to factual accuracy and verified reporting.
